IRIS
ULIVELLI, MONICA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.956
EU - Europa 7.902
AS - Asia 3.977
SA - Sud America 760
Continente sconosciuto - Info sul continente non disponibili 321
AF - Africa 289
OC - Oceania 18
Totale 23.223
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.763
GB - Regno Unito 2.017
IT - Italia 1.470
RU - Federazione Russa 1.352
SG - Singapore 1.336
CN - Cina 1.309
IE - Irlanda 926
BR - Brasile 597
SE - Svezia 516
UA - Ucraina 451
FR - Francia 390
VN - Vietnam 334
DE - Germania 324
HK - Hong Kong 298
KR - Corea 182
FI - Finlandia 176
ZA - Sudafrica 135
IN - India 96
TR - Turchia 89
CA - Canada 87
BD - Bangladesh 82
MX - Messico 57
NL - Olanda 55
ES - Italia 54
AR - Argentina 48
CI - Costa d'Avorio 45
NG - Nigeria 45
IQ - Iraq 40
PL - Polonia 36
AT - Austria 31
EC - Ecuador 31
SA - Arabia Saudita 26
VE - Venezuela 26
BE - Belgio 24
PK - Pakistan 23
CO - Colombia 22
JP - Giappone 21
AU - Australia 16
ID - Indonesia 14
CL - Cile 13
AE - Emirati Arabi Uniti 12
MA - Marocco 12
MY - Malesia 12
PH - Filippine 12
KE - Kenya 11
KZ - Kazakistan 11
JM - Giamaica 10
UZ - Uzbekistan 10
DZ - Algeria 9
PE - Perù 9
CH - Svizzera 8
CZ - Repubblica Ceca 8
LB - Libano 8
LT - Lituania 8
NP - Nepal 8
RO - Romania 8
EU - Europa 7
GR - Grecia 7
IL - Israele 7
JO - Giordania 7
PY - Paraguay 7
TN - Tunisia 7
AL - Albania 6
CR - Costa Rica 6
PA - Panama 6
SN - Senegal 6
DO - Repubblica Dominicana 5
EG - Egitto 5
MN - Mongolia 5
OM - Oman 5
AZ - Azerbaigian 4
BS - Bahamas 4
GE - Georgia 4
IR - Iran 4
LV - Lettonia 4
RS - Serbia 4
TT - Trinidad e Tobago 4
UY - Uruguay 4
BG - Bulgaria 3
BO - Bolivia 3
DK - Danimarca 3
EE - Estonia 3
GT - Guatemala 3
KG - Kirghizistan 3
LK - Sri Lanka 3
LU - Lussemburgo 3
NO - Norvegia 3
SI - Slovenia 3
SY - Repubblica araba siriana 3
XK - ???statistics.table.value.countryCode.XK??? 3
BB - Barbados 2
BW - Botswana 2
CY - Cipro 2
ET - Etiopia 2
GA - Gabon 2
HN - Honduras 2
HU - Ungheria 2
NI - Nicaragua 2
PS - Palestinian Territory 2
PT - Portogallo 2
Totale 22.887
Salva come PNG Salva come JPEG
Città #
Southend 1.830
Fairfield 976
Dallas 917
Dublin 914
Ashburn 806
Singapore 678
Chandler 522
Santa Clara 504
San Jose 493
Woodbridge 453
Wilmington 393
Milan 374
Jacksonville 369
Moscow 366
Houston 350
Cambridge 341
Seattle 341
Beijing 333
Hong Kong 280
Council Bluffs 249
Ann Arbor 243
Hefei 232
Siena 202
Seoul 181
Princeton 159
The Dalles 154
Menlo Park 138
Los Angeles 134
Rome 128
Johannesburg 127
Nanjing 115
New York 97
Ho Chi Minh City 95
Lauterbourg 88
Helsinki 87
Florence 77
Boardman 66
Hanoi 64
San Diego 64
Buffalo 63
Dong Ket 61
Munich 61
Columbus 60
São Paulo 56
San Mateo 55
Dearborn 50
Shanghai 46
Abidjan 45
Orem 45
Nanchang 44
Izmir 42
London 41
Abuja 40
Norwalk 37
Tianjin 34
Málaga 31
Redondo Beach 31
San Francisco 29
Chicago 28
Shenyang 27
Warsaw 27
Bengaluru 25
Brussels 24
Nuremberg 24
Toronto 24
Jinan 23
Amsterdam 22
Brooklyn 21
Changsha 21
Frankfurt am Main 21
Rio de Janeiro 21
Mexico City 20
Triggiano 20
Vienna 20
Fremont 19
Turin 19
Belo Horizonte 18
Denver 18
Boston 17
Guangzhou 17
Stockholm 17
Tokyo 17
Turku 17
Atlanta 16
Düsseldorf 16
Phoenix 16
Washington 16
Ankara 15
Kunming 15
Lappeenranta 15
Charlotte 14
Chennai 14
Da Nang 14
Naples 14
Ottawa 14
Quito 14
Brasília 13
Figino 13
Montreal 13
Zhengzhou 13
Totale 15.583
Salva come PNG Salva come JPEG
Nome #
Incidenza della sclerosi multipla in Toscana: uno studio basato su dati amministrativi 496
Which patients discontinue? Issues on Levodopa/carbidopa intestinal gel treatment: Italian multicentre survey of 905 patients with long-term follow-up 337
A mimic of first dorsal interosseus atrophy revealed by ultrasound study 330
Multiple sclerosis incidence in Tuscany from administrative data 309
Relevance of cognitive deterioration in early relapsing-remitting MS: a 3-year follow-up study 308
Dysfunctions of cortical excitability in drug-naïve posttraumatic stress disorder patients 307
Cross-Modal Audiovisual Modulation of Corticospinal Motor Synergies in Professional Piano Players: A TMS Study during Motor Imagery 306
Multiple sclerosis spatial cluster in Tuscany 285
Homocysteinemia control by cysteine in cerebral vascular patients after methionine loading test: evidences in physiological and pathological conditions in cerebro-vascular and multiple sclerosis patients 282
A real electro-magnetic placebo (REMP) device for sham transcranial magnetic stimulation (TMS) 279
Multiple sclerosis incidence in Tuscany from administrative data 275
Incidenza della sclerosi multipla in Toscana: uno studio basato sui dati amministrativi 269
Individual factors enhance poor health-related quality of life outcome in multiple sclerosis patients. Significance of predictive determinants 268
A clinically silent, but severe, duodenal complication of duodopa infusion 265
COVID-19 Severity in Multiple Sclerosis: Putting Data Into Context 264
Citalopram as treatment of depression in patients with epilepsy 263
Polysomnographic characterization of pergolide-induced sleep attacks in idiopathic PD. 260
Complessità terapeutico-assistenziale e management della sclerosi multipla: utilizzo di indicatori basati sul dato amministrativo 259
Relevance of 4-F4t-neuroprostane and 10-F4t-neuroprostane to neurological diseases 259
The Italian Multiple Sclerosis Register 257
Increasing prevalence of multiple sclerosis in Tuscany, Italy 254
Reliability, practice effects, and change indices for Rao's Brief Repeatable Battery 253
Prevalence of multiple sclerosis in tuscany (central Italy): a study based on validated administrative data 251
Non-motor symptoms in atypical and secondary parkinsonism: the PRIAMO study. 249
Antiparkinsonian drugs and visual hallucinations 249
Carbamazepine and carbamazepine-epoxide plasma levels during lamotrigine add-on [Livelli plasmatici di carbamazepina e carbamazepina epossido dopo add-on di lamotrigina] 248
Anhedonia and cognitive impairment in Parkinson's disease: Italian validation of the Snaith-Hamilton Pleasure Scale and its application in the clinical routine practice during the PRIAMO study 247
The control of hyperhomocysteinemia through thiol exchange mechanisms by mesna 246
CAT and MRI in the study of partial epilepsy: comparison of the 2 methods and correlations with EEG [TAC e RMN nello studio delle epilessie parziali: confronto tra le due metodiche e correlazioni con l'EEG] 245
Incidenza della sclerosi multipla in Toscana: uno studio basato su dati amministrativi 245
Prevalence of multiple sclerosis in Tuscany at 2011: a study based on validated administrative data 242
Clinical evidence of fluconazole-induced carbamazepine toxicity 241
Mortality trend for multiple sclerosis in Italy during the period 1980–2015 241
Breakthrough SARS-CoV-2 infections in MS patients on disease-modifying therapies 239
Increasing prevalence of multiple sclerosis in Tuscany: a study based on validated administrative data 239
La distribuzione geografica della sclerosi multipla in Toscana 238
Hypofunctioning of sensory gating mechanisms in patients with obsessive-compulsive disorder. 235
Effects of repetitive transcranial magnetic stimulation on chronic tinnitus: a randomised, crossover, double blind, placebo controlled study 234
Neurophysiological Correlates of Central Fatigue in Healthy Subjects and Multiple Sclerosis Patients before and after Treatment with Amantadine 234
Jitter of corticospinal neurons during repetitive transcranial magnetic stimulation. Method and possible clinical implications 232
The influence of diabetes and hyperglycemia on clinical course after intracerebral hemorrhage. 231
Association of celiac disease in patients with multiple sclerosis in Tuscany 229
Clinical and MRI measures to identify non-acute MOG-antibody disease in adults 228
Increasing prevalence of multiple sclerosis in Tuscany: a study based on validated administrative data 228
Breakthrough SARS-CoV-2 infections after COVID-19 mRNA vaccination in MS patients on disease modifying therapies during the Delta and the Omicron waves in Italy 227
Distinct olfactory cross-modal effects on the human motor system 221
Prevalence of multiple sclerosis in Tuscany: a study based on administrative data 221
Antibody response elicited by the SARS-CoV-2 vaccine booster in patients with multiple sclerosis: Who gains from it? 220
Emerging of new bioartificial corticospinal motor synergies using a robotic additional thumb 210
Detection of disability worsening in relapsing-remitting multiple sclerosis patients: a real-world roving Expanded Disability Status Scale reference analysis from the Italian Multiple Sclerosis Register 209
Early somatosensory processing during tonic muscle pain in humans: relation to loss of proprioception and motor 'defensive' strategies 208
Wearable haptic anklets for gait and freezing improvement in Parkinson’s disease: a proof-of-concept study 208
Repetitive transcranial magnetic stimulation (rTMS) in the treatment of obsessive-compulsive disorder (OCD) and Tourette's syndrome (TS) 207
Somatosensory evoked potentials reflect the upper limb motor performance in multiple sclerosis. 207
Effects of repetitive transcranial magnetic stimulation on movement-related cortical activity in humans 206
The PRIAMO study: A multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson's disease 206
SARS-CoV-2 serology after COVID-19 in multiple sclerosis: An international cohort study 205
Multicenter case-control study on restless legs syndrome in multiple sclerosis: the REMS study 204
The heart side of brain neuromodulation 203
Reliability of administrative data for the identification of Parkinson's disease cohorts 202
Imaging of the dopamine transporter predicts pattern of disease progression and response to levodopa in patients with schizophrenia and parkinsonism: a 2-year follow-up multicenter study 200
The olfactory side of Parkinson disease: Relevance for clinical practice 200
Feasibility of TMS in patients with new generation cochlear implants 200
Observational case-control study of the prevalence of chronic cerebrospinal venous insufficiency in multiple sclerosis: results from the CoSMo study 199
Mortality of Alzheimer’s disease in Italy from 1980 to 2015 197
Primary intraventricular haemorrhage in adults 197
Somatosensory processing during movement observation in humans 194
Slow repetitive TMS for drug-resistant epilepsy: clinical and EEG findings of a placebo-controlled trial 194
Regulation of redox forms of plasma thiols by albumin in multiple sclerosis after fasting and methionine loading test 193
Seizures after spontaneous supratentorial intracerebral hemorrhage 192
Mortality of Parkinson’s disease in Italy from 1980 to 2015 191
Reply to "Motor assessment of upper extremity function and its relation with fatigue, cognitive function and quality of life in multiple sclerosis patients" 190
Safety of the first dose of fingolimod for multiple sclerosis: Results of an open-label clinical trial 188
Human herpesvirus-6B active infection associated with relapsing bilateral anterior optic neuritis 187
Quantitative ColourDopplerSonography evaluation of cerebral venous outflow: a comparative study between patients with multiple sclerosis and controls 187
Modulation of high-frequency (600 Hz) somatosensory-evoked potentials after rTMS of the primary sensory cortex 186
Suprathreshold 0.3 Hz repetitive TMS prolongs the cortical silent period: potential implications for therapeutic trials in epilepsy 186
Effects of rehabilitation treatment of the upper limb in multiple sclerosis patients and predictive value of neurophysiological measures 186
Access to social security benefits among multiple sclerosis patients in Italy: A cross-sectional study 186
Effects of immunotherapy on motor cortex excitability in Stiff Person Syndrome 185
Repetitive Transcranial Magnetic Stimulation (rTMS) in the treatment of panic disorder (PD) with comorbid major depression 185
DMTs and Covid-19 severity in MS: a pooled analysis from Italy and France 184
Effect of SARS-CoV-2 mRNA vaccination in MS patients treated with disease modifying therapies 183
The PRIAMO study: age- and sex-related relationship between prodromal constipation and disease phenotype in early Parkinson’s disease 179
rTMS for PTSD: induced merciful oblivion or elimination of abnormal hypermnesia? 171
Frequency of the LRRK2 G2019S mutation in Italian patients affected by Parkinson's disease 170
Reduction of cortical myoclonus-related epileptic activity following slow-frequency rTMS 169
Temporal dynamics of memory trace formation in the human prefrontal cortex 169
Quantitative analysis of Lamotrigine in plasma and tablets by planar chromatography and comparison with liquid 165
Signs and symptoms of Covid‐19 in patients with multiple sclerosis 162
Prospective study of clinical, neurophysiological and urodynamic findings in multiple scleosis patients undergoing percutaneous transluminal venous angioplasty 157
Uveitis: A snapshot in the MOG antibody spectrum 149
Prevalence and impact of COVID-19 in Parkinson’s disease: evidence from a multi-center survey in Tuscany region 146
The role of ethnicity and native-country income in multiple sclerosis: the Italian multicentre study (MS-MigIT) 144
Grey Matter Atrophy and its Relationship with White Matter Lesions in Patients with Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease, Aquaporin-4 Antibody-Positive Neuromyelitis Optica Spectrum Disorder, and Multiple Sclerosis 141
The impact of PM2.5, PM10 and NO2 on Covid-19 severity in a sample of patients with multiple sclerosis: A case-control study 141
Does Risk of Hyperhomocysteinemia Depend on Thiol-Disulfide Exchange Reactions of Albumin and Homocysteine? 139
Human ventral parietal cortex plays a functional role on visuospatial attention and primary consciousness. A repetitive transcranial magnetic stimulation study 138
Pisa syndrome in Parkinson disease 138
Prevalence of chronic comorbidities in people with multiple sclerosis: descriptive study based on administrative data in Tuscany (Central Italy) 135
Totale 22.023
Salva come PNG Salva come JPEG
Categoria #
all - tutte 71.530
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 71.530
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.204 0 0 106 89 141 70 78 52 100 143 152 273
2022/20231.943 114 191 280 250 163 369 52 177 192 48 70 37
2023/20241.408 64 27 116 82 42 362 485 55 13 21 43 98
2024/20253.083 57 163 271 174 399 182 148 196 282 122 333 756
2025/20267.293 505 940 772 770 1.226 285 783 281 289 441 327 674
2026/2027956 388 234 334 0 0 0 0 0 0 0 0 0
Totale 23.223